心筋トロポニンの世界市場レポート 2025年

心筋トロポニン市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.4％で63億2,000万米ドルに成長します。予測期間の成長は、生活習慣に関連する心血管疾患の有病率の上昇、病院における心臓病治療室の拡大、在宅医療の採用拡大、個別化医療の成長、より効率的でコスト効率の高い診断ソリューションの需要などに起因しています。予測期間における主要動向としては、心臓医療におけるデータ解釈のための機械学習アルゴリズムの採用、急性冠症候群以外の心筋トロポニンの応用拡大、バイオマーカー同時分析のためのマルチプレックス検査の進歩、トロポニンと並ぶ新規バイオマーカーの開発、個別化医療などが挙げられます。

心臓関連疾患の罹患率の増加は、心筋トロポニン市場の今後の成長を促進すると予想されます。これらの疾患には、冠動脈疾患、心不全、不整脈、先天性心疾患など、心臓の構造や機能に影響を及ぼすさまざまな心血管疾患が含まれます。このような有病率増加の要因としては、人口の高齢化、座りがちなライフスタイル、不健康な食生活、肥満や高血圧の割合の増加などが挙げられます。心筋トロポニンは、特に心臓発作やその他の心臓の事象において、心筋の損傷を特定するための高感度のバイオマーカーとして機能するため、心臓に関連する問題の診断において重要な役割を果たしています。例えば、シンガポールの出入国管理局と保健省が発表した2023年の出生・死亡登録報告書によると、虚血性心疾患による死亡者数は5,302人で、2022年の5,290人からわずかに増加しています。このように、心臓疾患の有病率の増加は、心筋トロポニン市場を押し上げると予想されます。

心筋トロポニン市場の主要参入企業は、多項目コントロールによって高感度トロポニン検査の精度と信頼性を高めるために、ヒト血清ベースの品質管理などの新技術の開発に注力しています。この品質管理手法では、トロポニン濃度が既知のヒト血清を利用して検査性能を検証します。例えば、2023年5月、米国のバイオテクノロジー研究会社であるBio-Rad Laboratories, Inc.は、高感度トロポニン検査用に特別に調整された多項目品質管理システムであるCardiac Advanceを発売しました。これらのヒト血清ベースの液体コントロールは、InteliQ 3mLチューブ、Liquichek 3mLスタンダード、2.5mLコンパクトバイアルで提供されます。これらの製品には、トロポニン、CK-MB、BNP/proBNP、ミオグロビンなど10種類の心臓分析項目が含まれており、Siemensやロシュの検査プラットフォームと互換性があります。これらの製品は米国、欧州、一部のアジア市場で入手可能です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の心筋トロポニンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の心筋トロポニン市場：成長率分析
• 世界の心筋トロポニン市場の実績：規模と成長、2019～2024年
• 世界の心筋トロポニン市場の予測：規模と成長、2024～2029年、2034年
• 世界の心筋トロポニン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の心筋トロポニン市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• トロポニンI
• トロポニンT
• 世界の心筋トロポニン市場：検査場所別、実績と予測、2019～2024年、2024～2029年、2034年
• 実験室環境
• ポイントオブケア（POC）検査
• 世界の心筋トロポニン市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 急性冠症候群
• 心筋梗塞
• うっ血性心不全
• その他
• 世界の心筋トロポニン市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 診断センター
• 在宅ケア環境
• その他
• 世界の心筋トロポニン市場、トロポニンIのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 心筋トロポニン I（cTnI）
• 筋トロポニンI
• 世界の心筋トロポニン市場、トロポニンTのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 心筋トロポニン T（cTnT）
• 骨格筋トロポニンT

第7章 地域別・国別分析

• 世界の心筋トロポニン市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の心筋トロポニン市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 心筋トロポニン市場：競合情勢
• 心筋トロポニン市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Merck KGaA
  • Siemens Healthineers AG

第31章 その他の大手企業と革新的企業

• Becton Dickinson and Company
• Laboratory Corporation of America Holdings（Labcorp）
• Zoetis Inc.
• bioMerieux SA
• Beckman Coulter Inc.
• QuidelOrtho Corporation
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• Radiometer Medical ApS
• Randox Laboratories Ltd.
• Fujirebio Diagnostics Inc.
• Meso Scale Diagnostics LLC.
• Singulex Inc.
• Diazyme Laboratories Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 心筋トロポニン市場、2029年：新たな機会を提供する国
• 心筋トロポニン市場、2029年：新たな機会を提供するセグメント
• 心筋トロポニン市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Cardiac troponin refers to a set of proteins located in the heart muscle (myocardium) that play a crucial role in regulating heart contractions. These troponins are components of the muscle fiber proteins that manage the interaction between actin and myosin, which are vital for muscle contraction. They serve as biomarkers used for diagnosing heart injuries, particularly in the case of heart attacks.

The primary types of cardiac troponin are troponin I and troponin T. Troponin I is a protein present in heart muscle cells that aids in the regulation of muscle contractions, and increased levels of Troponin I in the bloodstream may indicate heart injury or stress, making it critical for precise cardiac diagnostics. Testing can be conducted in laboratory environments as well as through point-of-care (PoC) testing, applicable in scenarios such as acute coronary syndrome, myocardial infarction, and congestive heart failure, among others. The end users of this testing include hospitals, diagnostic centers, home care settings, and more.

The cardiac troponin market research report is one of a series of new reports from the business research company that provides cardiac troponin market statistics, including cardiac troponin industry global market size, regional shares, competitors with an cardiac troponin market share, detailed cardiac troponin market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac troponin industry. This cardiac troponin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac troponin market size has grown rapidly in recent years. It will grow from $3.85 billion in 2024 to $4.25 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, increasing awareness and early diagnosis of heart conditions, expanding healthcare infrastructure in emerging markets, growth in the elderly population, introduction of high-sensitivity cardiac troponin assays.

The cardiac troponin market size is expected to see rapid growth in the next few years. It will grow to $6.32 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to rising prevalence of lifestyle-related cardiovascular conditions, expansion of cardiac care units in hospitals, increasing adoption of home healthcare, growth in personalized medicine, and demand for more efficient and cost-effective diagnostic solutions. Major trends in the forecast period include adoption of machine learning algorithms for data interpretation in cardiac care, expanding applications of cardiac troponin beyond acute coronary syndrome, advancements in multiplex testing for simultaneous biomarker analysis, development of novel biomarkers alongside troponin, and personalized medicine.

The rising incidence of heart-related diseases is anticipated to drive the growth of the cardiac troponin market in the future. These diseases include various cardiovascular issues such as coronary artery disease, heart failure, arrhythmias, and congenital heart defects, all of which impact the heart's structure and functionality. Factors contributing to this increasing prevalence include aging populations, sedentary lifestyles, unhealthy dietary habits, and escalating rates of obesity and hypertension. Cardiac troponin plays a vital role in diagnosing heart-related issues as it serves as a highly sensitive biomarker for identifying heart muscle damage, especially in the context of heart attacks and other cardiac events. For example, the Report on Registration of Births and Deaths 2023 from Singapore's Immigration and Checkpoints Authority and Ministry of Health indicated that deaths from ischemic heart diseases totaled 5,302, marking a slight rise from 5,290 in 2022. Thus, the growing prevalence of heart conditions is expected to boost the cardiac troponin market.

Key players in the cardiac troponin market are concentrating on developing new technologies, such as human serum-based quality control, to enhance the accuracy and reliability of high-sensitivity troponin testing through multi-analyte controls. This quality control approach utilizes human serum with known troponin levels to validate assay performance. For instance, in May 2023, Bio-Rad Laboratories, Inc., a biotechnology research firm based in the U.S., launched Cardiac Advance, a multi-analyte quality control system specifically tailored for high-sensitivity troponin testing. These liquid, human-serum-based controls are provided in InteliQ 3-mL tubes, Liquichek 3-mL standards, and 2.5-mL compact vials. They include 10 cardiac analytes, such as troponin, CK-MB, BNP/proBNP, and myoglobin, and are compatible with testing platforms from Siemens and Roche. These products are available in the U.S., Europe, and select Asian markets.

In February 2022, Prolight Diagnostics AB, a Swedish medical equipment manufacturer, acquired Psyros Diagnostics Ltd. for $5.78 million. This acquisition aims to integrate Psyros Diagnostics' advanced single-molecule counting technology into Prolight Diagnostics' offerings, resulting in the development of highly sensitive, rapid, and cost-effective point-of-care (POC) testing solutions. This move enhances their capabilities across various clinical areas and solidifies their presence in the POC market. Psyros Diagnostics Ltd., a UK-based company, has created the Psyros POC system, a device designed to measure the cardiac troponin biomarker.

Major companies operating in the cardiac troponin market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings (Labcorp), Zoetis Inc., bioMerieux SA, Beckman Coulter Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Radiometer Medical ApS, Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Meso Scale Diagnostics LLC., Singulex Inc., Diazyme Laboratories Inc., Response Biomedical Corporation, Eurolyser Diagnostica GmbH, LifeSign LLC

North America was the largest region in the cardiac troponin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac troponin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac troponin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac troponin market consists of sales of diagnostic assays, test kits, point-of-care testing devices, and high-sensitivity troponin tests. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Troponin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac troponin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac troponin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac troponin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Troponin I; Troponin T
• 2) By Location Of Testing: Laboratory Setting; Point Of Care (Poc) Testing
• 3) By Application: Acute Coronary Syndrome; Myocardial Infraction; Congestive Heart Failure; Other Applications
• 4) By End User: Hospitals; Diagnostic Centers; Homecare Setting; Other End Users
• Subsegments:
• 1) By Troponin I: Cardiac Troponin I (cTnI); Muscle Troponin I
• 2) By Troponin T: Cardiac Troponin T (cTnT); Skeletal Troponin T
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Siemens Healthineers AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Troponin Market Characteristics

3. Cardiac Troponin Market Trends And Strategies

4. Cardiac Troponin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cardiac Troponin Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cardiac Troponin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cardiac Troponin Market Growth Rate Analysis
• 5.4. Global Cardiac Troponin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cardiac Troponin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cardiac Troponin Total Addressable Market (TAM)

6. Cardiac Troponin Market Segmentation

• 6.1. Global Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Troponin I
• Troponin T
• 6.2. Global Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Setting
• Point Of Care (Poc) Testing
• 6.3. Global Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Coronary Syndrome
• Myocardial Infraction
• Congestive Heart Failure
• Other Applications
• 6.4. Global Cardiac Troponin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Centres
• Homecare Setting
• Other End Users
• 6.5. Global Cardiac Troponin Market, Sub-Segmentation Of Troponin I, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Troponin I (cTnI)
• Muscle Troponin I
• 6.6. Global Cardiac Troponin Market, Sub-Segmentation Of Troponin T, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Troponin T (cTnT)
• Skeletal Troponin T

7. Cardiac Troponin Market Regional And Country Analysis

• 7.1. Global Cardiac Troponin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cardiac Troponin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Troponin Market

• 8.1. Asia-Pacific Cardiac Troponin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Troponin Market

• 9.1. China Cardiac Troponin Market Overview
• 9.2. China Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Troponin Market

• 10.1. India Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Troponin Market

• 11.1. Japan Cardiac Troponin Market Overview
• 11.2. Japan Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Troponin Market

• 12.1. Australia Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Troponin Market

• 13.1. Indonesia Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Troponin Market

• 14.1. South Korea Cardiac Troponin Market Overview
• 14.2. South Korea Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Troponin Market

• 15.1. Western Europe Cardiac Troponin Market Overview
• 15.2. Western Europe Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Troponin Market

• 16.1. UK Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Troponin Market

• 17.1. Germany Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Troponin Market

• 18.1. France Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Troponin Market

• 19.1. Italy Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Troponin Market

• 20.1. Spain Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Troponin Market

• 21.1. Eastern Europe Cardiac Troponin Market Overview
• 21.2. Eastern Europe Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Troponin Market

• 22.1. Russia Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Troponin Market

• 23.1. North America Cardiac Troponin Market Overview
• 23.2. North America Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Troponin Market

• 24.1. USA Cardiac Troponin Market Overview
• 24.2. USA Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Troponin Market

• 25.1. Canada Cardiac Troponin Market Overview
• 25.2. Canada Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Troponin Market

• 26.1. South America Cardiac Troponin Market Overview
• 26.2. South America Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Troponin Market

• 27.1. Brazil Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Troponin Market

• 28.1. Middle East Cardiac Troponin Market Overview
• 28.2. Middle East Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Troponin Market

• 29.1. Africa Cardiac Troponin Market Overview
• 29.2. Africa Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Troponin Market Competitive Landscape And Company Profiles

• 30.1. Cardiac Troponin Market Competitive Landscape
• 30.2. Cardiac Troponin Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Troponin Market Other Major And Innovative Companies

• 31.1. Becton Dickinson and Company
• 31.2. Laboratory Corporation of America Holdings (Labcorp)
• 31.3. Zoetis Inc.
• 31.4. bioMerieux SA
• 31.5. Beckman Coulter Inc.
• 31.6. QuidelOrtho Corporation
• 31.7. Sysmex Corporation
• 31.8. Bio-Rad Laboratories Inc.
• 31.9. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• 31.10. Radiometer Medical ApS
• 31.11. Randox Laboratories Ltd.
• 31.12. Fujirebio Diagnostics Inc.
• 31.13. Meso Scale Diagnostics LLC.
• 31.14. Singulex Inc.
• 31.15. Diazyme Laboratories Inc.

32. Global Cardiac Troponin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Troponin Market

34. Recent Developments In The Cardiac Troponin Market

35. Cardiac Troponin Market High Potential Countries, Segments and Strategies

• 35.1 Cardiac Troponin Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cardiac Troponin Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cardiac Troponin Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer